Brian M. Hahn
2015
In 2015, Brian M. Hahn earned a total compensation of $718.7K as Chief Financial Officer at GlycoMimetics, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $93,594 |
|---|---|
| Option Awards | $310,490 |
| Salary | $314,600 |
| Total | $718,684 |
Hahn received $314.6K in salary, accounting for 44% of the total pay in 2015.
Hahn also received $93.6K in non-equity incentive plan and $310.5K in option awards.
Rankings
In 2015, Brian M. Hahn's compensation ranked 9,423rd out of 13,638 executives tracked by ExecPay. In other words, Hahn earned more than 30.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,423 out of 13,638 | 31st |
Division Manufacturing | 3,588 out of 5,190 | 31st |
Major group Chemicals And Allied Products | 1,308 out of 1,854 | 29th |
Industry group Drugs | 1,066 out of 1,528 | 30th |
Industry Pharmaceutical Preparations | 833 out of 1,182 | 30th |
Source: SEC filing on April 20, 2017.
Hahn's colleagues
We found three more compensation records of executives who worked with Brian M. Hahn at GlycoMimetics in 2015.
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019